Real-time enrollment status for this clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:46 AM UTC
| NCT Number | NCT06914999 |
| Recruiting Status | Recruiting |
| Condition | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | October 22, 2025 (Oct 22, 2025) |
As of July 17, 2026: Clinical trial NCT06914999 is currently recruiting participants. This early_phase1 study for clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06914999 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06914999 was last updated Oct 22, 2025 (October 22, 2025). HelloStudys verifies this status automatically.